Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Insights Into Patients' Experience With Type 1 Diabetes: Exit Interviews From Phase III Studies of Sotagliflozin.

Ervin C, Joish VN, Evans E, DiBenedetti D, Reaney M, Preblick R, Castro R, Danne T, Buse JB, Lapuerta P.

Clin Ther. 2019 Oct 3. pii: S0149-2918(19)30479-5. doi: 10.1016/j.clinthera.2019.09.003. [Epub ahead of print]

PMID:
31587812
2.

Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.

Dovc K, Piona C, Yeşiltepe Mutlu G, Bratina N, Jenko Bizjan B, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T.

Diabetes Care. 2019 Oct 1. pii: dc190895. doi: 10.2337/dc19-0895. [Epub ahead of print]

PMID:
31575640
3.

Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.

Kordonouri O, Lange K, Biester T, Datz N, Kapitzke K, von dem Berge T, Weiskorn J, Danne T.

Diabet Med. 2019 Sep 9. doi: 10.1111/dme.14130. [Epub ahead of print]

PMID:
31498923
4.

Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes.

Danne T, Pettus J, Giaccari A, Cariou B, Rodbard H, Weinzimer SA, Bonnemaire M, Sawhney S, Stewart J, Wang S, Castro RC, Garg SK.

Diabetes Technol Ther. 2019 Sep;21(9):471-477. doi: 10.1089/dia.2019.0157.

5.

Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial.

Baker C, Wason S, Banks P, Sawhney S, Chang A, Danne T, Gesty-Palmer D, Kushner JA, McGuire DK, Mikell F, O'Neill M, Peters AL, Strumph P.

Diabetes Obes Metab. 2019 Nov;21(11):2440-2449. doi: 10.1111/dom.13825. Epub 2019 Aug 1.

PMID:
31264767
6.

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol.

Ziegler AG, Achenbach P, Berner R, Casteels K, Danne T, Gündert M, Hasford J, Hoffmann VS, Kordonouri O, Lange K, Elding Larsson H, Lundgren M, Snape MD, Szypowska A, Todd JA, Bonifacio E; and the GPPAD Study group.

BMJ Open. 2019 Jun 28;9(6):e028578. doi: 10.1136/bmjopen-2018-028578.

7.

Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports.

Thalange N, Biester T, Danne T.

Diabetes Ther. 2019 Aug;10(4):1219-1237. doi: 10.1007/s13300-019-0641-3. Epub 2019 Jun 11. Review.

8.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

9.

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice.

Evans M, Ceriello A, Danne T, De Block C, DeVries JH, Lind M, Mathieu C, Nørgaard K, Renard E, Wilmot EG.

Diabetes Obes Metab. 2019 Sep;21(9):2039-2047. doi: 10.1111/dom.13798. Epub 2019 Jun 19. Review.

10.

Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.

van Mark G, Lanzinger S, Sziegoleit S, Putz FJ, Durmaz M, Borscheller M, Danne T, Seufert J, Holl RW, Bramlage P.

Adv Ther. 2019 Jul;36(7):1628-1641. doi: 10.1007/s12325-019-00983-w. Epub 2019 May 22.

PMID:
31119688
11.

Beyond type 2 diabetes: sodium glucose co-transporter-inhibition in type 1 diabetes.

Biester T, Kordonouri O, Danne T.

Diabetes Obes Metab. 2019 Apr;21 Suppl 2:53-61. doi: 10.1111/dom.13659.

PMID:
31081591
12.

Comparison of pharmacokinetics and the exposure-response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus.

Busse D, Tang W, Scheerer M, Danne T, Biester T, Sokolov V, Boulton D, Parkinson J.

Br J Clin Pharmacol. 2019 Aug;85(8):1820-1828. doi: 10.1111/bcp.13981. Epub 2019 Jun 20.

PMID:
31077437
13.

Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.

Bode BW, Iotova V, Kovarenko M, Laffel LM, Rao PV, Deenadayalan S, Ekelund M, Larsen SF, Danne T.

Diabetes Care. 2019 Jul;42(7):1255-1262. doi: 10.2337/dc19-0009. Epub 2019 May 10.

PMID:
31076415
14.

Diagnosis, Therapy and Follow-up of Diabetes Mellitus in Children and Adolescents.

Neu A, Bürger-Büsing J, Danne T, Dost A, Holder M, Holl RW, Holterhus PM, Kapellen T, Karges B, Kordonouri O, Lange K, Müller S, Raile K, Schweizer R, Sengbusch SV, Stachow R, Wagner V, Wiegand S, Ziegler R.

Exp Clin Endocrinol Diabetes. 2019 Jun;127(6):341-352. doi: 10.1055/a-0869-0210. Epub 2019 Apr 29. No abstract available.

PMID:
31035299
15.

Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.

Bramlage P, Lanzinger S, van Mark G, Hess E, Fahrner S, Heyer CHJ, Friebe M, Seufert J, Danne T, Holl RW.

Cardiovasc Diabetol. 2019 Mar 16;18(1):33. doi: 10.1186/s12933-019-0837-x.

16.

Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases.

van Mark G, Lanzinger S, Barion R, Degenhardt M, Badis S, Noll H, Danne T, Bramlage P, Seufert J, Holl RW.

Ther Adv Endocrinol Metab. 2019 Feb 28;10:2042018819830867. doi: 10.1177/2042018819830867. eCollection 2019.

17.

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.

Danne T, Cariou B, Buse JB, Garg SK, Rosenstock J, Banks P, Kushner JA, McGuire DK, Peters AL, Sawhney S, Strumph P.

Diabetes Care. 2019 May;42(5):919-930. doi: 10.2337/dc18-2149. Epub 2019 Mar 4.

PMID:
30833371
18.

New Insulins, Biosimilars, and Insulin Therapy.

Danne T, Heinemann L, Bolinder J.

Diabetes Technol Ther. 2019 Feb;21(S1):S57-S78. doi: 10.1089/dia.2019.2505. Review. No abstract available.

PMID:
30785319
19.

Screening for asymptomatic β-cell autoimmunity in young children.

Ziegler AG, Hoffmann GF, Hasford J, Larsson HE, Danne T, Berner R, Penno M, Koralova A, Dunne J, Bonifacio E.

Lancet Child Adolesc Health. 2019 May;3(5):288-290. doi: 10.1016/S2352-4642(19)30028-8. Epub 2019 Feb 10. No abstract available.

PMID:
30745054
20.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M.

Diabetes Care. 2019 Jun;42(6):1147-1154. doi: 10.2337/dc18-2316. Epub 2019 Feb 6. Review.

PMID:
30728224
21.

The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials.

Thalange N, Deeb L, Klingensmith G, Franco DR, Bardtrum L, Tutkunkardas D, Danne T.

Pediatr Diabetes. 2019 May;20(3):314-320. doi: 10.1111/pedi.12821. Epub 2019 Feb 10.

PMID:
30666772
22.

New approach for detection of LDL-hypercholesterolemia in the pediatric population: The Fr1dolin-Trial in Lower Saxony, Germany.

Kordonouri O, Lange K, Boettcher I, Christoph J, Marquardt E, Tombois C, Galuschka L, Stiller D, Mueller I, Roloff F, Aschemeier B, Danne T.

Atherosclerosis. 2019 Jan;280:85-91. doi: 10.1016/j.atherosclerosis.2018.11.011. Epub 2018 Nov 17.

PMID:
30496984
23.

DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.

Biester T, Nir J, Remus K, Farfel A, Muller I, Biester S, Atlas E, Dovc K, Bratina N, Kordonouri O, Battelino T, Philip M, Danne T, Nimri R.

Diabetes Obes Metab. 2018 Nov 26. doi: 10.1111/dom.13585. [Epub ahead of print]

PMID:
30478937
24.

The current landscape of European registries for rare endocrine conditions.

Ali SR, Bryce J, Cools M, Korbonits M, Beun JG, Taruscio D, Danne T, Dattani M, Dekkers OM, Linglart A, Netchine I, Nordenstrom A, Patocs A, Persani L, Reisch N, Smyth A, Sumnik Z, Visser WE, Hiort O, Pereira AM, Ahmed SF.

Eur J Endocrinol. 2019 Jan 1;180(1):89-98. doi: 10.1530/EJE-18-0861.

25.

Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol.

Garg SK, Peters AL, Buse JB, Danne T.

Diabetes Technol Ther. 2018 Sep;20(9):571-575. doi: 10.1089/dia.2018.0246. Epub 2018 Aug 21. No abstract available.

PMID:
30129772
26.

Regional differences in type 2 diabetes treatment and outcomes in Germany-An analysis of the German DPV and DIVE registries.

Hartmann B, Bramlage P, Lanzinger S, Danne T, Hummel M, Kaltheuner M, Raddatz D, Rathmann W, Reuter HM, Seufert J, Holl RW.

Diabetes Metab Res Rev. 2018 Nov;34(8):e3049. doi: 10.1002/dmrr.3049. Epub 2018 Sep 19.

PMID:
30051605
27.

ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes.

Danne T, Phillip M, Buckingham BA, Jarosz-Chobot P, Saboo B, Urakami T, Battelino T, Hanas R, Codner E.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:115-135. doi: 10.1111/pedi.12718. No abstract available.

PMID:
29999222
28.

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study.

Danne T, Cariou B, Banks P, Brandle M, Brath H, Franek E, Kushner JA, Lapuerta P, McGuire DK, Peters AL, Sawhney S, Strumph P.

Diabetes Care. 2018 Sep;41(9):1981-1990. doi: 10.2337/dc18-0342. Epub 2018 Jun 24.

PMID:
29937431
29.

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.

Buse JB, Garg SK, Rosenstock J, Bailey TS, Banks P, Bode BW, Danne T, Kushner JA, Lane WS, Lapuerta P, McGuire DK, Peters AL, Reed J, Sawhney S, Strumph P.

Diabetes Care. 2018 Sep;41(9):1970-1980. doi: 10.2337/dc18-0343. Epub 2018 Jun 24.

30.

Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care.

Danne T, Biester T, Kordonouri O.

Diabetes Technol Ther. 2018 Jun;20(S2):S269-S277. doi: 10.1089/dia.2018.0081.

PMID:
29916741
31.

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians.

Nimri R, Dassau E, Segall T, Muller I, Bratina N, Kordonouri O, Bello R, Biester T, Dovc K, Tenenbaum A, Brener A, Šimunović M, Sakka SD, Nevo Shenker M, Passone CG, Rutigliano I, Tinti D, Bonura C, Caiulo S, Ruszala A, Piccini B, Giri D, Stein R, Rabbone I, Bruzzi P, Omladič JŠ, Steele C, Beccuti G, Yackobovitch-Gavan M, Battelino T, Danne T, Atlas E, Phillip M.

Diabetes Obes Metab. 2018 Oct;20(10):2458-2466. doi: 10.1111/dom.13408. Epub 2018 Jul 18.

PMID:
29885025
32.

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

Biester T, Kordonouri O, Danne T.

Ther Adv Endocrinol Metab. 2018 May;9(5):157-166. doi: 10.1177/2042018818763247. Epub 2018 Mar 19. Review.

33.

Editorial Tribute: Mark A. Sperling, MD, Editor-in-Chief, Pediatric Diabetes 2000-2017.

Menon R, Becker D, Arslanian S, Kordonouri O, Trucco M, Pietropaolo M, Danne T.

Pediatr Diabetes. 2018 May;19(3):345. doi: 10.1111/pedi.12661. No abstract available.

PMID:
29695032
34.

Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry.

Danne T, Schwandt A, Biester T, Heidtmann B, Rami-Merhar B, Haberland H, Müther S, Khodaverdi S, Haak T, Holl RW; DPV Initiative.

Pediatr Diabetes. 2018 Aug;19(5):979-984. doi: 10.1111/pedi.12658. Epub 2018 Apr 15.

PMID:
29446511
35.

New Insulins, Biosimilars, and Insulin Therapy.

Danne T, Heinemann L, Bolinder J.

Diabetes Technol Ther. 2018 Feb;20(S1):S55-S70. doi: 10.1089/dia.2018.2505. Review. No abstract available.

PMID:
29437477
36.

Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002-1009.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, Hanas R, Waldron S, Beck RW, Calvi-Gries F, Mathieu C.

Diabetes Care. 2018 Mar;41(3):640. doi: 10.2337/dc18-er03. Epub 2018 Jan 10. No abstract available.

37.

Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.

Writing Group for the TRIGR Study Group, Knip M, Åkerblom HK, Al Taji E, Becker D, Bruining J, Castano L, Danne T, de Beaufort C, Dosch HM, Dupre J, Fraser WD, Howard N, Ilonen J, Konrad D, Kordonouri O, Krischer JP, Lawson ML, Ludvigsson J, Madacsy L, Mahon JL, Ormisson A, Palmer JP, Pozzilli P, Savilahti E, Serrano-Rios M, Songini M, Taback S, Vaarala O, White NH, Virtanen SM, Wasikowa R.

JAMA. 2018 Jan 2;319(1):38-48. doi: 10.1001/jama.2017.19826.

38.

Risk of recurrent severe hypoglycemia remains associated with a past history of severe hypoglycemia up to 4 years: Results from a large prospective contemporary pediatric cohort of the DPV initiative.

Pacaud D, Hermann JM, Karges B, Rosenbauer J, Danne T, Dürr R, Herbst A, Lindauer S, Müther S, Pötzsch S, Raile K, Witsch M, Holl RW; DPV Initiative.

Pediatr Diabetes. 2018 May;19(3):493-500. doi: 10.1111/pedi.12610. Epub 2017 Dec 8.

PMID:
29218766
39.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

40.

Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes.

Skinner TC, Lange KS, Hoey H, Mortensen HB, Aanstoot HJ, Castaňo L, Skovlund S, Swift PG, Cameron FJ, Dorchy HR, Palmert MR, Kaprio E, Robert JJ, Danne T, Neu A, Shalitin S, Chiarelli F, Chiari G, Urakami T, Njølstad PR, Jarosz-Chobot PK, Roche EF, Castro-Correia CG, Kocova M, Åman J, Schönle E, Barrett TG, Fisher L, de Beaufort CE; Hvidoere Study Group.

Pediatr Diabetes. 2018 May;19(3):559-565. doi: 10.1111/pedi.12606. Epub 2017 Nov 20.

PMID:
29159931
41.

Pharmacological Properties of Faster-Acting Insulin Aspart.

Biester T, Kordonouri O, Danne T.

Curr Diab Rep. 2017 Sep 23;17(11):101. doi: 10.1007/s11892-017-0931-y. Review.

PMID:
28940145
42.

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.

Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, Pozzilli P, Gesty-Palmer D, Lapuerta P, Simó R, Danne T, McGuire DK, Kushner JA, Peters A, Strumph P.

N Engl J Med. 2017 Dec 14;377(24):2337-2348. doi: 10.1056/NEJMoa1708337. Epub 2017 Sep 13.

43.

Pediatric diabetes training for healthcare professionals in Europe: Time for change.

Kime NH, Waldron S, Webster E, Lange K, Zinken K, Danne T, Aschemeier B, Sumnik Z, Cinek O, Raposo JF, Vazeou A, Bratina N, Campbell F.

Pediatr Diabetes. 2018 May;19(3):578-585. doi: 10.1111/pedi.12573. Epub 2017 Sep 7.

PMID:
28880485
44.

Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.

Dovc K, Macedoni M, Bratina N, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T.

Diabetologia. 2017 Nov;60(11):2157-2167. doi: 10.1007/s00125-017-4395-z. Epub 2017 Aug 24.

45.

[Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE].

Bohn B, Bramlage P, Wagner C, Kaltheuner M, Welp R, Sziegoleit S, Zimmermann A, Reuter HM, Hummel M, Gloyer J, Holl RW, Danne T.

Wien Med Wochenschr. 2018 Nov;168(15-16):415-422. doi: 10.1007/s10354-017-0589-8. Epub 2017 Aug 21. German.

PMID:
28828553
46.

Lean diabetes in middle-aged adults: A joint analysis of the German DIVE and DPV registries.

Hartmann B, Lanzinger S, Bramlage P, Groß F, Danne T, Wagner S, Krakow D, Zimmermann A, Malcharzik C, Holl RW.

PLoS One. 2017 Aug 21;12(8):e0183235. doi: 10.1371/journal.pone.0183235. eCollection 2017.

47.

Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries.

Lyons SK, Hermann JM, Miller KM, Hofer SE, Foster NC, Rami-Merhar BM, Aleppo G, Seufert J, DiMeglio LA, Danne T, Maahs DM, Holl RW.

Diabetes Care. 2017 Oct;40(10):e139-e140. doi: 10.2337/dc17-0403. Epub 2017 Aug 2. No abstract available.

48.

Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, Hanas R, Waldron S, Beck RW, Calvi-Gries F, Mathieu C.

Diabetes Care. 2017 Aug;40(8):1002-1009. doi: 10.2337/dc16-1990. Epub 2017 May 25. Erratum in: Diabetes Care. 2018 Jan 10;:.

49.

[Attaching an Insulin Pump].

Biester T, Biester S, Kordonouri O, Danne T.

Dtsch Med Wochenschr. 2017 May;142(10):758-762. doi: 10.1055/s-0042-119235. Epub 2017 May 17. German. No abstract available.

PMID:
28514824
50.

[The Way to Closed Loop - Dream and Reality].

Biester T, Danne T, Kordonouri O.

Dtsch Med Wochenschr. 2017 May;142(10):731-736. doi: 10.1055/s-0042-119492. Epub 2017 May 17. German.

PMID:
28514821

Supplemental Content

Support Center